(Q33875995)

29 July 2017

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells (English)

1 reference

medroxyprogesterone acetate

29 July 2017

1 reference

1 reference

Bentel JM

1

1 reference

29 July 2017

Birrell SN

2

1 reference

29 July 2017

Pickering MA

3

1 reference

29 July 2017

Holds DJ

4

1 reference

29 July 2017

Horsfall DJ

5

1 reference

29 July 2017

Tilley WD

6

1 reference

29 July 2017

1 August 1999

1 reference

Molecular and Cellular Endocrinology

29 July 2017

1 reference

29 July 2017

154

1 reference

29 July 2017

11-20

1 reference

29 July 2017

1-2

1 reference

Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH)

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Androgens induce divergent proliferative responses in human breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Role of the androgen receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Functional activities of the A and B forms of the human androgen receptor in response to androgen receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

The Effect of Medroxyprogesterone Acetate on the Pituitary-Adrenal Axis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

The binding of progesterone, R-5020 and ORG-2058 to progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Development and characterization of primary cultures of smooth muscle cells from the fibromuscular stroma of the guinea pig prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Endocrine treatment of breast cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Characterization and expression of a cDNA encoding the human androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

A structural role for hormone in the thyroid hormone receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Atomic structure of progesterone complexed with its receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

A canonical structure for the ligand-binding domain of nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900109-4

7 January 2021

10.1016/S0303-7207(99)00109-4

Identifiers

DOI

1 reference

29 July 2017

1 reference